SANA
Sana Biotechnology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$770.87M
P/E Ratio
—
EPS
$-0.92
Beta
2.16
52W High
$6.55
52W Low
$2.43
50-Day MA
$3.23
200-Day MA
$3.84
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sana Biotechnology Inc
Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-168.57M |
| Operating Margin | 0.00% |
| Return on Equity | -147.40% |
| Return on Assets | -27.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.60 |
| Price-to-Book | 6.44 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -1.08 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $278.29M |
| Float | $169.91M |
| % Insiders | 6.51% |
| % Institutions | 82.83% |
Historical Volatility
HV 10-Day
63.15%
HV 20-Day
54.53%
HV 30-Day
56.37%
HV 60-Day
63.09%
HV Rank
4.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.57 target)
2
Strong Buy6
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026